The stock appears to be inexpensive relative to next year's earnings estimates and earnings growth expectations while having great near- and long-term earnings growth estimates. The company pays a great dividend and has a phenomenal return on equity. The risk/reward ratio is tilted towards higher risk at this point but it is about equal.
AbbVie Inc (NYSE:ABBV) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a broad line of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. On January 29, 2016, the company reported fourth quarter earnings of $1.13 per share which beat analyst estimates by $0.01. In the past year the company's stock is down 1% and is losing to the S&P 500, which has lost 0.3% in the same time frame.
Source: Seeking Alpha
Related Articles:
- 8 Select High-Yield S&P 500 Dividend Stocks
- A Winning Investment Strategy
- 7 Dividend Stocks With A 20% Yield In 20 Years
- 5 Industrial Strength Dividend Growth Stocks With Yields In Excess Of 3%
- Finding Low Risk Dividend Stocks
Dividend Growth Stocks News
- 2 Dividend Stocks to Double Up on Right Now - Yahoo Finance - 5/16/2025
- The Best Warren Buffett Dividend Stocks - Kiplinger - 5/15/2025
- 3 Dividend Stocks to Buy Now That Are Crushing the S&P 500 in 2025 - The Motley Fool - 5/16/2025
- 3 Dividend Stocks That Could Double Your Monthly Income - 24/7 Wall St. - 5/16/2025
- Retire Like A Boss: 3 Fantastic Dividend Stocks Yielding 7–14% - Seeking Alpha - 5/16/2025
- Automatic Data Processing Inc. (ADP) Dividend Stock Analysis - 5/16/2025
- Air Products and Chemicals Inc. (APD) Dividend Stock Analysis - 5/9/2025
- Waste Management, Inc. (WM) Dividend Stock Analysis - 5/2/2025
- Wal-Mart Stores, Inc. (WMT) Dividend Stock Analysis - 4/25/2025
- Abbott Laboratories (ABT) Dividend Stock Analysis - 4/18/2025
This Stock Yields 4% And Is A Great Long-Term Hold But Has Suffered
Posted by D4L | Tuesday, April 19, 2016 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.